Subscribe

TJ Cradick, PhD

Articles by TJ Cradick, PhD

TJ Cradick, PhD, on A Potential Cure for HIV With EBT-101

ByTJ Cradick, PhD

October 27th 2022

The chief scientific officer of Excision BioTherapeutics discussed the phase 1/2 clinical trial of the CRISPR gene editing therapy.

Latest Updated Articles

Trending on CGTlive®

Around the Helix: Cell and Gene Therapy Company Updates – October 22, 2025

AskBio’s Heart Failure Gene Therapy AB-1002 Shows Ability to Improve NYHA Class in Phase 1 Trial

AAVantgarde’s Stargardt Gene Therapy AAVB-039 Garners FDA Orphan Drug Designation, Cleared for Trial in UK

© 2025 MJH Life Sciences^®

All rights reserved.